Počet záznamov: 1
kyselina valproová
SYS d014635 LBL 00000cz--a2200000o--4500 005 20250606214219.5 008 921111|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.241.081.944.509.900 065 $a D10.251.400.895.593.900 066 $a 01 $c 03 150 $a kyselina valproová $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Dipropyl Acetate $2 eng 450 $w v $a Divalproex $2 eng 450 $w v $a Sodium Valproate $2 eng 450 $w v $a dipropylacetát $2 slo 450 $w v $a divalproex $2 slo 450 $w v $a valproan sodný $2 slo 450 $w v $a valproát sodný $2 slo 550 $7 sllk_us_auth*d000927 $Y Anticonvulsants $w P $a antikonvulzíva 550 $7 sllk_us_auth*d004791 $Y Enzyme Inhibitors $w P $a inhibítory enzýmov 550 $7 sllk_us_auth*d018682 $Y GABA Agents $w P $a látky pôsobiace na GABA-ergické systémy 550 $7 sllk_us_auth*d018692 $Y Antimanic Agents $w P $a antimaniaká 665 $a 1991; was VALPROATE 1979-1990; was DIPROPYL ACETATE see under VALERATES 1975-1978 $2 eng 665 $a Valerates (1966-1974) $2 eng 680 9-
$i A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. $2 eng 750 -2
$a Valproic Acid $2 eng 980 $x M
Počet záznamov: 1